Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) Sees Large Decr
Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) Sees Large Decrease in Short Interest
Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Get Free Report) was the recipient of a significant decrease in short interest during the month of December. As of December 15th, there was short interest totalling 303,000 shares, a decrease of 17.6% from the November 30th total of 367,800 shares. Based on an average daily volume of 2,400,000 shares, […]
Related Keywords
, Dimensional Fund Advisors, Processa Pharmaceuticals Inc, Maxim Group, Sigma Securities, News Ratings For Processa Pharmaceuticals Daily, Nasdaq, Raymond James Financial Services Advisors Inc, Institutional Investors Weigh In On Processa Pharmaceuticals, Processa Pharmaceuticals Stock Performance, Citadel Advisors, Processa Pharmaceuticals, Walleye Capital, Get Free Report, James Financial Services Advisors, Processa Pharmaceuticals Daily, Nasdaq Pcsa, Hpcsa, Medical, Stocks, Options, Put, Call,